A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer



Status:Active, not recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:July 2007
End Date:March 2016

Use our guide to learn which trials are right for you!

A Randomized Phase III Trial of Neoadjuvant Therapy for Patients With Palpable and Operable HER2-Positive Breast Cancer Comparing the Combination of Trastuzumab Plus Lapatinib to Trastuzumab and to Lapatinib Administered With Weekly Paclitaxel Following AC Accompanied by Correlative Science Studies to Identify Predictors of Pathologic Complete Response

The primary purpose of this study is to determine whether breast cancer tumors respond (as
measured by pathologic complete response: the absence of microscopic evidence of invasive
tumor cells in the breast) to combined chemotherapy of AC(doxorubicin and cyclophosphamide)
followed by paclitaxel plus trastuzumab or lapatinib or both given before surgery to
patients with HER2-positive breast cancer. Trastuzumab will also be given to all patients
after surgery. The study will also evaluate the toxic effects of the chemotherapy
combination, including effects on the heart, and will determine survival and
progression-free survival 5 years after treatment. Also, the study will look at whether
there are gene expression profiles in the tumor tissue that can predict pathologic complete
response.

Women with breast cancers that overexpress HER2 are at greater risk for disease progression
and death than women whose tumors do not overexpress HER2. Trastuzumab, a recombinant
humanized monoclonal antibody against the extracellular domain of the HER2 protein blocks
downstream signaling of HER2 and substantially improves the efficacy of chemotherapy in
women with metastatic and early-stage HER2-positive breast cancers. Because resistance to
trastuzumab eventually results in progressive disease in the metastatic setting and
contributes to recurrence following adjuvant trastuzumab-based therapy, it is important to
develop agents other than trastuzumab that target HER2 signaling through different
mechanisms of action. Lapatinib is an oral, small molecule, dual tyrosine kinase inhibitor
of HER2 and EGFR. Lapatinib has shown a lack of cross-resistance with trastuzumab in
preclinical studies and activity in women with HER2-positive, metastatic breast cancer that
has progressed during trastuzumab treatment. Trastuzumab blocks the downstream signaling of
HER2 by binding to the extracellular domain of the receptor. Lapatinib binds to the
intracellular domains of HER2 and EGFR and prevents activation of downstream signaling
pathways. Because of this different mechanism of action, lapatinib may be effective in
trastuzumab-resistant disease. The study will also provide important safety information on
trastuzumab and lapatinib combinations immediately following anthracycline exposure, and
also provide an initial direct comparison of cardiac effects of trastuzumab and lapatinib
when incorporated into a standard sequential AC followed by weekly paclitaxel (neo)adjuvant
regimen.

Availability of a second agent that can interrupt HER2-signaling pathways through completely
different mechanisms than those of trastuzumab offers the potential for further improvement
in the management of patients with HER2-overexpressing breast cancer in both the adjuvant
and metastatic setting. Co-administration of both trastuzumab and lapatinib with
chemotherapy may be important in improving outcomes in subsets of HER2-positive breast
cancers. However, use of two inhibitors of the HER2 pathway will increase costs and may
increase toxicity, so it will be important to identify the subsets of patients who would
benefit from the dual therapy. Inhibition of HER2 with a single agent clearly is sufficient
for many patients as evidenced by the results of the trastuzumab trials. Therefore,
co-administration to unselected populations of women with HER2-positive breast cancers would
not represent an optimal approach. Given the activity of lapatinib, it is likely that it
will also be sufficiently active in inhibiting HER2-pathway activation in some patients to
allow for its use as the sole inhibitor of the HER2 pathway. Different populations may also
derive greater benefit from one of the HER2-blocking agents relative to the other.
Identification of potential predictive factors for pathologic complete response to the
combination or to either agent administered alone in neoadjuvant trials would provide
important information for adjuvant trials designed to definitively address these important
issues.

This study will compare 3 combined chemotherapy regimens: AC followed by paclitaxel plus
trastuzumab and lapatinib, AC followed by paclitaxel plus lapatinib, and AC followed by
paclitaxel plus trastuzumab given before surgery to patients with HER2-positive breast
cancer.

Inclusion criteria:

- Female

- 18 years or older

- ECOG performance status of 0 or 1

- Primary breast tumor palpable and measures greater than or equal to 2.0 cm by
physical exam

- Diagnosis of invasive adenocarcinoma made by core needle biopsy

- Breast cancer determined to be HER2-positive

- LVEF assessment by MUGA scan or ECG within 3 months prior to randomization

- Blood counts must meet the following criteria:

- ANC greater than or equal to 1200/mm3

- Platelet count greater than or equal to 100,000/mm3

- Hemoglobin greater than or equal to 10 g/dL

- Serum creatinine less than or equal to ULN for the lab

- Adequate hepatic function by these criteria:

- Total bilirubin less than or equal to the ULN for the lab unless the patient has
a bilirubin elevation greater than ULN to 1.5 x ULN resulting from Gilbert's
disease or similar syndrome due to slow conjugation of bilirubin; and

- Alkaline phosphatase less than or equal to 2.5 x ULN; and

- AST less than or equal to 1.5 x ULN for the lab.

- If skeletal pain present or alkaline phosphatase greater than ULN (but less than or
equal to 2.5 x ULN), bone scan or PET scan must not demonstrate metastatic disease

- If AST or alkaline phosphatase greater than ULN , liver imaging (CT, MRI or PET scan)
must not demonstrate definitive metastatic disease and the requirements in criterion
for hepatic function must be met

- Able to swallow oral medications

Exclusion criteria:

- FNA alone to diagnose the primary tumor

- Excisional biopsy or lumpectomy was performed prior to randomization

- Surgical axillary staging procedure prior to randomization. Exceptions: 1) FNA or
core biopsy of an axillary node for any patient, and 2) although not recommended, a
pre-neoadjuvant therapy SN biopsy for patients with clinically negative axillary
nodes.

- Tumors clinically staged as T4

- Ipsilateral cN2b or cN3 disease (Patients with cN1 or cN2a disease are eligible)

- Definitive clinical or radiologic evidence of metastatic disease

- Synchronous bilateral invasive breast cancer

- Requirement for chronic use of any of the medications or substances specified in the
protocol

- Treatment including RT, chemotherapy, and/or targeted therapy for the currently
diagnosed breast cancer prior to randomization

- Any sex hormonal therapy, e.g., birth control pills, ovarian hormone replacement
therapy, etc. (These patients are eligible if therapy is discontinued prior to
randomization)

- Continued therapy with any hormonal agent such as raloxifene, tamoxifen, or other
SERM. (Patients are eligible only if these medications are discontinued prior to
randomization)

- Prior history of breast cancer, including DCIS (Patients with a history of LCIS are
eligible)

- Prior therapy with anthracyclines, taxanes, trastuzumab, or lapatinib for any
malignancy

- Other malignancies unless the patient is considered to be disease-free for 5 or more
years prior to randomization and is deemed by her physician to be at low risk for
recurrence. Patients with the following cancers are eligible if diagnosed and treated
within the past 5 years: carcinoma in situ of the cervix, carcinoma in situ of the
colon, melanoma in situ, and basal cell and squamous cell carcinoma of the skin.

- Cardiac disease that would preclude the use of the drugs included in the B-41
treatment regimens. This includes but is not confined to:

- Active cardiac disease:

- angina pectoris requiring the use of anti-anginal medication;

- ventricular arrhythmias except for benign premature ventricular
contractions controlled by medication;

- conduction abnormality requiring a pacemaker;

- supraventricular and nodal arrhythmias requiring a pacemaker or not
controlled with medication; and

- clinically significant valvular disease.

- History of cardiac disease:

- myocardial infarction;

- congestive heart failure; or

- cardiomyopathy.

- Uncontrolled hypertension, defined as blood pressure greater than 150/90 mm/Hg on
antihypertensive therapy

- History of or current symptomatic interstitial pneumonitis or pulmonary fibrosis or
definitive evidence of interstitial pneumonitis or pulmonary fibrosis described on CT
or chest x-ray in asymptomatic patients

- Sensory/motor neuropathy greater than or equal to grade 2, as defined by the NCI's
CTCAE v3.0

- Malabsorption syndrome, ulcerative colitis, resection of the stomach or small bowel,
or other disease significantly affecting gastrointestinal function

- Other non-malignant systemic disease that would preclude treatment with any of the
treatment regimens or would prevent required follow-up

- Conditions that would prohibit administration of corticosteroids

- Administration of any investigational agents within 30 days before randomization

- Pregnancy or lactation
We found this trial at
104
sites
894
mi
from
Cleveland, OH
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
(919) 962-2211
University of North Carolina at Chapel Hill Carolina’s vibrant people and programs attest to the...
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
2500 Campus Rd
Honolulu, Hawaii 96822
(808) 956-8111
Univ of Hawaii Honolulu Community College is an integral part of the University of Hawai?i,...
3715
mi
from
Honolulu, HI
Click here to add this to my saved trials
101 Jessup Hall
Iowa City, Iowa 52242
(319) 335-3500
University of Iowa With just over 30,000 students, the University of Iowa is one of...
428
mi
from
Iowa City, IA
Click here to add this to my saved trials
740 South Limestone Street
Lexington, Kentucky 40536
725
mi
from
Lexington, KY
Click here to add this to my saved trials
Korman Research Pavilion%2c Suite 100
Philadelphia, Pennsylvania 19141
215-456-7215
1226
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
(412) 624-4141
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
4502 Medical Drive
San Antonio, Texas 78284
(210) 567-7000
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
571
mi
from
San Antonio, TX
Click here to add this to my saved trials
Akron, Ohio 44304
899
mi
from
Akron, OH
Click here to add this to my saved trials
Albany, Georgia 31701
884
mi
from
Albany, GA
Click here to add this to my saved trials
1308
mi
from
Albany, NY
Click here to add this to my saved trials
1200 S Cedar Crest Blvd
Allentown, Pennsylvania 18103
(610) 402-8000
Lehigh Valley Hospital At Lehigh Valley Health Network, we continually go the extra mile to...
1209
mi
from
Allentown, PA
Click here to add this to my saved trials
5301 East Huron River Drive
Ann Arbor, Michigan 48106
1.877.590.5995
CCOP - Michigan Cancer Research Consortium The Community Clinical Oncology Program (CCOP) is a comprehensive...
801
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
936
mi
from
Augusta, GA
Click here to add this to my saved trials
Aurora, Colorado 80045
402
mi
from
Aurora, CO
Click here to add this to my saved trials
6701 N Charles St
Baltimore, Maryland 21204
(443) 849-2000
Greater Baltimore Medical Center The 255-bed medical center (acute and sub-acute care) is located on...
1147
mi
from
Baltimore, MD
Click here to add this to my saved trials
Baltimore, Maryland 21237
1154
mi
from
Baltimore, MD
Click here to add this to my saved trials
Billings, Montana 59101
780
mi
from
Billings, MT
Click here to add this to my saved trials
Boston, Massachusetts 02118
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Burlington, North Carolina 27215
1018
mi
from
Burlington, NC
Click here to add this to my saved trials
Canton, Ohio 44710
900
mi
from
Canton, OH
Click here to add this to my saved trials
Charlotte, North Carolina 28203
957
mi
from
Charlotte, NC
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
(312) 942-5000
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Coeur d'Alene, Idaho 83814
1176
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Colorado Springs, Colorado 80909
384
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
1 Hospital Dr
Columbia, Missouri 65212
(573) 882-2100
University of Missouri-Ellis Fischel Ellis Fischel Cancer Center's team of physician specialists and other trained...
306
mi
from
Columbia, MO
Click here to add this to my saved trials
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Columbus, Ohio 43215
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Danville, Pennsylvania 17882
1119
mi
from
Danville, PA
Click here to add this to my saved trials
Dayton, Ohio 45429
747
mi
from
Dayton, OH
Click here to add this to my saved trials
2300 N Edward St
Decatur, Illinois 62526
(217) 876-8121
Decatur Memorial Hospital An American flag bearing only 48 stars waved above Decatur Memorial Hospital...
499
mi
from
Decatur, IL
Click here to add this to my saved trials
Denver, Colorado 80205
409
mi
from
Denver, CO
Click here to add this to my saved trials
409
mi
from
Denver, CO
Click here to add this to my saved trials
Des Moines, Iowa 52501
367
mi
from
Des Moines, IA
Click here to add this to my saved trials
Detroit, Michigan 48202
841
mi
from
Detroit, MI
Click here to add this to my saved trials
2799 W Grand Blvd
Detroit, Michigan 48202
(313) 916-2600
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
841
mi
from
Detroit, MI
Click here to add this to my saved trials
600
mi
from
Elk Grove, IL
Click here to add this to my saved trials
Glens Falls, New York 12801
1321
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Grand Rapids, Michigan 49503
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
80 Seymour St
Hartford, Connecticut 6102
(860) 545-5000
The Hartford Hospital Hartford Hospital is the major teaching hospital affiliated with the University of...
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Hershey, Pennsylvania 17033
1147
mi
from
Hershey, PA
Click here to add this to my saved trials
3718
mi
from
Honolulu, HI
Click here to add this to my saved trials
Indianapolis, Indiana 46260
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Kalamazoo, Michigan 49007
718
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Kansas City, Missouri 64131
194
mi
from
Kansas City, MO
Click here to add this to my saved trials
777
mi
from
Knoxville, TN
Click here to add this to my saved trials
La Jolla, California 92037
1145
mi
from
La Jolla, CA
Click here to add this to my saved trials
Lafayette, Colorado 80026
421
mi
from
Lafayette, CO
Click here to add this to my saved trials
401 West Greenlawn Avenue
Lansing, Michigan 48910
(517) 975-9500
Michigan State University - Breslin Cancer Center This busy clinic provides care to thousands of...
778
mi
from
Lansing, MI
Click here to add this to my saved trials
1172
mi
from
Long Beach, CA
Click here to add this to my saved trials
Long Beach, California 90813
1171
mi
from
Long Beach, CA
Click here to add this to my saved trials
Louisville, Kentucky 40202
657
mi
from
Louisville, KY
Click here to add this to my saved trials
368
mi
from
Lubbock, TX
Click here to add this to my saved trials
Marshfield, Wisconsin 54449
621
mi
from
Marshfield, WI
Click here to add this to my saved trials
1029
mi
from
Mebane, NC
Click here to add this to my saved trials
8701 W Watertown Plank Rd
Milwaukee, Wisconsin
(414) 955-8296
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
636
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Minneapolis, Minnesota 55414
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Minneapolis, Minnesota 55416
548
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Mobile, Alabama 36688
735
mi
from
Mobile, AL
Click here to add this to my saved trials
1 Medical Center Drive
Morgantown, West Virginia 26506
304-598-4800
West Virginia University Hospitals Inc. WVU Healthcare is two corporations, University Health Associates and WVU...
970
mi
from
Morgantown, WV
Click here to add this to my saved trials
Naperville, Illinois 60566
588
mi
from
Naperville, IL
Click here to add this to my saved trials
New Brunswick, New Jersey 08901
1263
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
New Orleans, Louisiana 70121
694
mi
from
New Orleans, LA
Click here to add this to my saved trials
201 Lyons Ave
Newark, New Jersey 07112
(973) 926-7000
Newark Beth Israel Medical Center Newark Beth Israel Medical Center, a regional care, teaching hospital...
1278
mi
from
Newark, NJ
Click here to add this to my saved trials
330 Washington St #220
Norwich, Connecticut 06360
(860) 886-8362
Eastern Connecticut Hematology and Oncology Associates In 1985 Dr. Dennis Slater moved from Memorial Sloan-Kettering...
1389
mi
from
Norwich, CT
Click here to add this to my saved trials
Omaha, Nebraska 74136
261
mi
from
Omaha, NE
Click here to add this to my saved trials
Orange, California 92868
1154
mi
from
Orange, CA
Click here to add this to my saved trials
Orlando, Florida 32806
1144
mi
from
Orlando, FL
Click here to add this to my saved trials
1081
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Palo Alto, California 94304
1330
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Parkersburg, West Virginia 26101
885
mi
from
Parkersburg, WV
Click here to add this to my saved trials
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pittsburgh, Pennsylvania 15212
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
4800 Friendship Ave
Pittsburgh, Pennsylvania 15224
(412) 578-5000
Western Pennsylvania Hospital Featuring 308 private patient beds, West Penn Hospital has served Bloomfield and...
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Plainfield, Illinois 60585
575
mi
from
Plainfield, IL
Click here to add this to my saved trials
Richmond, Virginia 23298
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Royal Oak, Michigan 48073
839
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Sacramento, California 95816
1282
mi
from
Sacramento, CA
Click here to add this to my saved trials
San Diego, California 92120
1136
mi
from
San Diego, CA
Click here to add this to my saved trials
Santa Rosa, California 95403
1293
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Scranton, Pennsylvania 18501
1204
mi
from
Scranton, PA
Click here to add this to my saved trials
Seattle, Washington 98109
1411
mi
from
Seattle, WA
Click here to add this to my saved trials
Seattle, Washington 99519
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
336
mi
from
Sioux City, IA
Click here to add this to my saved trials
Souix Falls, South Dakota 57104
408
mi
from
Souix Falls, SD
Click here to add this to my saved trials
671
mi
from
South Bend, IN
Click here to add this to my saved trials
Southfield, Michigan 48075
835
mi
from
Southfield, MI
Click here to add this to my saved trials
Spartanburg, South Carolina 29303
903
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Springfield, Illinois 62526
499
mi
from
Springfield, IL
Click here to add this to my saved trials
Springfield, Missouri 65804
254
mi
from
Springfield, MO
Click here to add this to my saved trials
3437 Caroline Mall
St. Louis, Missouri 63110
416
mi
from
St. Louis, MO
Click here to add this to my saved trials
St. Louis, Missouri 63131
415
mi
from
St. Louis, MO
Click here to add this to my saved trials
1193
mi
from
Syracuse, NY
Click here to add this to my saved trials
Tacoma, Washington 98405
1408
mi
from
Tacoma, WA
Click here to add this to my saved trials
Toronto, Ontario
1047
mi
from
Toronto,
Click here to add this to my saved trials
Tulsa, Oklahoma 74136
155
mi
from
Tulsa, OK
Click here to add this to my saved trials
509 W. University Avenue
Urbana, Illinois 61801
(217) 383-3516
CCOP - Carle Cancer Center The Carle Cancer Center Community Clinical Oncology Program (CCOP) in...
541
mi
from
Urbana, IL
Click here to add this to my saved trials
Vallejo, California 94589
1327
mi
from
Vallejo, CA
Click here to add this to my saved trials
5255 Loughboro Rd NW
Washington, District of Columbia 20016
(202) 537-4000
Sibley Memorial Hospital Sibley Memorial Hospital, in Northwest Washington, D.C., has a distinguished history of...
1127
mi
from
Washington,
Click here to add this to my saved trials
West Reading, Pennsylvania 19612
1187
mi
from
West Reading, PA
Click here to add this to my saved trials
Wheeling, West Virginia 26003
933
mi
from
Wheeling, WV
Click here to add this to my saved trials